Skip to main content
Oxford University Hospitals NHS Foundation Trust

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Cancer Services

Cancer Panels

R208 Inherited Breast & Ovarian Cancer
R207 Inherited Ovarian Cancer
R209 Inherited Colorectal Cancer (with or without polyposis)
R210 Inherited MMR Deficiency (Lynch Syndrome)
R210.1 Microsatellite Instability
R210.2/R210.5 MMR gene panel (currently offering Lynch like panel)
R210.3 BRAF V600E (only offered in conjunction with methylation test)
R210.4 MLH1 hypermethylation
R211 Inherited Polyposis panel
Prostate Cancer Panel
PTEN related conditions
Li-Fraumeni (TP53)
Von Hippel Lindau (VHL)
Inherited pancreatic cancer panel
Hereditary Mixed Polyposis

Endocrine related tumours:
R217 Endocrine Neoplasia including (AIP, CDC73, CDKN1B,MEN1,RET)
R223 Inherited phaeochromocytoma and paraganglioma (FH,MAX, RET,SDHA,SDHAF2,SDHB,SDHC,SDHD,TMEM127,VHL)
R218 Multiple Endocrine Neoplasia type 2 (RET exons 5, 8, 10, 11, 13, 14, 15 &16)
R226 Inherited parathyroid cancer (CDC73)
Familial Isolated Pituitary Adenoma (AIP)
Multiple Endocrine Neoplasia type 1 (MEN1)
Multiple Endocrine Neoplasia type 1 (MEN4)

Testing for previously identified familial variants, as clinically appropriate, is available.

For non NHS test requests, individual gene / syndrome testing is available on request, as appropriate.


Last updated: 12-Nov-2019 by Claire Scott